miR-221 and Parkinson’s disease: A biomarker with therapeutic
potential
Mohammad Yasin Zamanian1,2, Mehraveh Sadeghi
Ivraghi3, Reena Gupta4, KDV
Prasad5, 6, Hashem O. Alsaab7,
Beneen M. Hussien8, Hazem Ahmed9,
Montather F. Ramadan10, Maryam
Golmohammadi11*, Nikta Nikbakht12*,
Tuba Oz13, and Małgorzata Kujawska13
1Neurophysiology Research Center, Hamadan University
of Medical Sciences, Hamadan 6718773654, Iran.
2Department of Physiology, School of Pharmacy, Hamadan
University of Medical Sciences, Hamadan 6718773654, Iran.
3School of Medicine, Qazvin University of Medical
Sciences, Qazvin, Iran.
4Institute of Pharmaceutical Research, GLA University,
District-Mathura, U. P., India.
5Symbiosis Institute of Business Management (SIBM),
Hyderabad, India
6Symbiosis International (Deemed University) (SIU) Off
Bangalore Highway Kothur Mandal Village, Mahabubnagar, Hyderabad,
Telangana, India.
7Pharmaceutics and Pharmaceutical Technology, Taif
University, Taif, Saudi Arabia
8Medical Laboratory Technology Department, College of
Medical Technology, The Islamic University, Najaf, Iraq.
9 Medical Technical College, Al-Farahidi University,
Baghdad, Iraq.
10College of Dentistry, Al-Ayen University, Thi-Qar,
Iraq.
11School of Medicine, Shahid Beheshti University of
Medical Sciences, Tehran 198887355.
12Department of Physical Medicine and Rehabilitation,
School of Pharmacy, Hamadan University of Medical Sciences, Hamadan
6718773654, Iran.
13 Department of Toxicology, Poznan University of
Medical Sciences, Dojazd 30, Poznań, Poland.
* Corresponding Authors:
-Dr. Maryam Golmohammadi, School of Medicine, Shahid Beheshti University
of Medical Sciences, Tehran, Iran; Tel: +989187018850; Email Address:
maryam.golmohammadi.sbmu@gmail.com
-Dr. Nikta Nikbakht, Department of Physical Medicine and Rehabilitation,
School of Pharmacy, Hamadan University of Medical Sciences, Hamadan
6718773654, Iran. Email Address:
drniktanikbakht@gmail.com